| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/14/1993 | EP0536295A1 Certain azacycloalkyl imidazopyrimidines; a new class of gaba brain receptor ligands |
| 04/14/1993 | EP0536279A1 Substituted 1-(alkoxyphenyl)piperazines with cns and antihypertensive activity |
| 04/14/1993 | EP0536277A1 Amantadine hydrochloride suspension with enhanced dissolution characteristics for use in soft gelatin capsules |
| 04/14/1993 | EP0536269A1 The use of inositoltrisphosphate for the preparing of medicaments |
| 04/14/1993 | EP0536262A1 Substituted histidines |
| 04/14/1993 | EP0536255A1 Ophthalmic suspensions. |
| 04/14/1993 | EP0536224A1 Antiviral agents containing heteropolytungstate |
| 04/14/1993 | EP0536208A1 1,2-dihydro-3h-dibenzisoquinoline-1,3-dione anticancer agents |
| 04/14/1993 | EP0536177A1 Thrombin inhibitors based on the amino acid sequence of hirudin |
| 04/14/1993 | EP0536163A1 Aromatic pyrrolidine and thiazolidine amides |
| 04/14/1993 | EP0536119A1 Immunoregulatory agents |
| 04/14/1993 | EP0446268B1 Use of acetyl d-carnitine in the therapeutic treatment of glaucoma |
| 04/14/1993 | CN1070913A Imidazoindolizine derivatives and process for preparation thereof |
| 04/14/1993 | CN1070911A Therapeutic compounds |
| 04/14/1993 | CN1070910A Thiazolylbenzofuran derivatives, processes for preparation thereof and pharmaceutical composition comprising same |
| 04/14/1993 | CN1070909A Thiourea derivatives and antimicrobial agent and antiulcer agent containing same |
| 04/14/1993 | CN1070906A Substituted aminopropanes, processes for their prepartion and their use |
| 04/14/1993 | CN1020252C Prepn. of rifampin eye ointment |
| 04/13/1993 | US5202456 Anticarcinogenic agents; methylating transferase inhibitors; farnesyl or geranyl sulfur-, oxygen or selenium-containing derivatives |
| 04/13/1993 | US5202447 Process of producing 5,6,7-trinor-4,8-inter-m-phenylene pgi2 derivatives |
| 04/13/1993 | US5202424 Mesangial cell-derived receptors for advanced glycosylation endproducts and uses thereof |
| 04/13/1993 | US5202355 Administering for diabetic neuropathy |
| 04/13/1993 | US5202354 Composition and method for reducing acetaldehyde toxicity |
| 04/13/1993 | US5202352 Antitumor agents |
| 04/13/1993 | US5202351 Treating hyperlipemia, atherosclerosis |
| 04/13/1993 | US5202349 Substituted phenylacetylenes, pharmaceutical compositions containing these compounds and processes for the preparation of these compounds and compositions |
| 04/13/1993 | US5202348 Thiarubrine antifungal agents |
| 04/13/1993 | US5202344 N-substituted lactams useful as cholecystokinin antagonists |
| 04/13/1993 | US5202341 Hydroxystyrene compounds having tyrosine kinase inhibiting activity |
| 04/13/1993 | US5202339 Hydantoin derivatives |
| 04/13/1993 | US5202337 Antibacterial agent, feed additive |
| 04/13/1993 | US5202334 Pyrazolo[1,5-a]pyridine compounds, and production and use thereof |
| 04/13/1993 | US5202331 Therapeutic agent for dysuria comprising alpha-phenyl-alpha-pyridylalkanoic acid derivatives |
| 04/13/1993 | US5202328 Substituted fused pyrimidinones |
| 04/13/1993 | US5202327 Phosphorus-containing hmg-coa reductase inhibitors |
| 04/13/1993 | US5202325 Use of ergoline derivatives in treating emesis |
| 04/13/1993 | US5202323 Antithrombotic, inotropic, vasodilator, antiallergen |
| 04/13/1993 | US5202321 Antihistamine, antiallergens, antiinflammatory agents |
| 04/13/1993 | US5202319 Substituted 3-amino-2,3,4,5-tetrahydro-1-aryloxy-3-benzazepines |
| 04/13/1993 | US5202317 Synthetic drug molecules that mimic metalloenzymes |
| 04/13/1993 | US5202315 Antiboiotic |
| 04/13/1993 | US5202314 10-thioethyl-steroids |
| 04/13/1993 | US5202313 Bilobalide derivatives, their applications and formulations containing them |
| 04/13/1993 | US5202312 Antiarthritic agents, antiallergens, antidiabetic agents |
| 04/13/1993 | US5202244 Process for producing aphidicolin using the microrganism verticillium sp |
| 04/13/1993 | US5202159 Preparation method of microdispersed tablet formulation of spray-dried sodium diclofenac enteric-coated microcapsules |
| 04/13/1993 | US5202130 Suppression of eczematous dermatitis by calcium transport inhibition |
| 04/13/1993 | US5202126 Protein synthesis promoter |
| 04/13/1993 | US5202121 Thrombolytic compositions |
| 04/13/1993 | US5202110 Formulations for delivery of beclomethasone diproprionate by metered dose inhalers containing no chlorofluorocarbon propellants |
| 04/13/1993 | US5202029 High performance liquid chromatography |
| 04/13/1993 | CA1316180C L-dopa derivatives or their acid addition salts, process for producing same and their use |
| 04/13/1993 | CA1316177C 1,2-bis(aminomethyl) cyclobutane platinum complexes |
| 04/13/1993 | CA1316171C Cephalosporin derivatives |
| 04/13/1993 | CA1316170C Glycosidic derivatives |
| 04/13/1993 | CA1316112C Anxiolytic compositions containing dioxopiperidine derivatives |
| 04/13/1993 | CA1316111C Cholestyramine compositions and method for preparation thereof |
| 04/13/1993 | CA1316110C Sustained release matrix formulations |
| 04/13/1993 | CA1316104C Biocide composition |
| 04/12/1993 | WO1993007118A1 9-substituted bicyclo[3.3.0]octane derivatives, for use as txa2 antagonists |
| 04/12/1993 | CA2097930A1 9-substituted bicyclo[3.3.0]octane derivatives, for use as txa2 antagonists |
| 04/12/1993 | CA2080253A1 Benzimidazole phosphono-amino acids |
| 04/12/1993 | CA2080172A1 Method for blocking neoplastic transformation of cells induced by ras oncogenes |
| 04/12/1993 | CA2080158A1 Method for blocking neoplastic transformation of cells induced by ras oncogenes employing bisphosphonates or analogs thereof |
| 04/12/1993 | CA2079971A1 Anti-endotoxin compounds and related molecules and methods |
| 04/11/1993 | CA2080110A1 Organic compounds |
| 04/10/1993 | CA2080054A1 17beta-substituted aza-androstane derivatives |
| 04/10/1993 | CA2079428A1 Pharmaceutical compounds |
| 04/10/1993 | CA2079309A1 Antifungal agent |
| 04/09/1993 | CA2079938A1 Solid formulation containing amide derivative and method of manufacturing the formulation |
| 04/08/1993 | WO1993007155A1 Vanadyl complexes of hydroxamate chelators and pharmaceutical compositions comprising them |
| 04/08/1993 | DE4203285A1 Pharmaceutical prepn. contg. combination of aspirin and nocloprost - useful as analgesic, antipyretic and antirheumatic compsn. without damage to gastrointestinal tract |
| 04/08/1993 | DE4132701A1 Verfahren zur herstellung von staerkeabbauprodukten mit einer engen molekulargewichtsverteilung A process for preparing staerkeabbauprodukten having a narrow molecular weight distribution |
| 04/08/1993 | CA2097608A1 Vanadyl complexes of hydroxamate chelators and pharmaceutical compositions comprising them |
| 04/08/1993 | CA2079982A1 Substituted pyrazino (2,3-d)-pyrimidinones as angiotensin ii antagonists |
| 04/08/1993 | CA2079770A1 Angiotensin ii antagonists incorporating a substituted 1, 3-benzodioxole and 1, 3-benzodithiole |
| 04/08/1993 | CA2079733A1 Hydrobromide of dc-89 derivative |
| 04/08/1993 | CA2079705A1 Prostaglandin analogs |
| 04/08/1993 | CA2078723A1 Win 49596-finasteride method of use and compositions |
| 04/07/1993 | EP0536036A1 Cardioprotective tocopherol analogs |
| 04/07/1993 | EP0536035A1 1,8-Benzonaphthyridine derivatives and antimicrobial compositions |
| 04/07/1993 | EP0535926A1 (Hetero-arylmethoxy) indoles as inhibitors of leukotriene biosynthesis |
| 04/07/1993 | EP0535925A1 (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
| 04/07/1993 | EP0535924A1 (Bicyclic-azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
| 04/07/1993 | EP0535923A1 (Azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
| 04/07/1993 | EP0535884A1 Use of AICA riboside compounds for the treatment and prevention of tissue damage due to decreased blood flow |
| 04/07/1993 | EP0535841A1 Use of a combination of iburofen and codeine for the treatment of pain |
| 04/07/1993 | EP0535722A1 3,4-Dehydropiperidine derivatives |
| 04/07/1993 | EP0535719A2 Treatment of hemorrhoids with artemisinin and derivates |
| 04/07/1993 | EP0535704A1 Glycyrrhizin suppository |
| 04/07/1993 | EP0535645A2 Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs, a process for their preparation and their use as medicaments |
| 04/07/1993 | EP0535626A1 Use of 4-amino-1-(2-pyridyl)piperidines as anti-convulsivant and anti-epileptic agents |
| 04/07/1993 | EP0535567A1 Liposomes containing volatile inhalation anaesthetics, their preparation and their use |
| 04/07/1993 | EP0535548A1 Inhibitor of atherosclerotic intimal thickening |
| 04/07/1993 | EP0535545A1 Artificial tears containing oil and wax |
| 04/07/1993 | EP0535529A2 Indole derivatives and anti-ulcer compositions |
| 04/07/1993 | EP0535528A1 Antibacterial 5-Nitro-1-methyl-imidazolyl-3-terbutyl-2-hydroxy-aryl-carbinols |
| 04/07/1993 | EP0535521A2 Condensed oxazole and thiazole derivatives as leukotriene biosynthesis inhibitors |
| 04/07/1993 | EP0535496A1 (1-Indanon-2yl)methylpiperidines, intermediates and a process for their preparation and their use as medicaments |
| 04/07/1993 | EP0535465A1 Cyclic substituted imidazolylpropen acid derivatives as angiotensin II antagonists |